Apyx Medical Corp. (APYX) Tops Q1 EPS by 2c ; Offers Guidance

Apyx Medical Corp. (NASDAQ: APYX) reported Q1 EPS of ($0.10), $0.02 better than the analyst estimate of ($0.12). Revenue for the quarter came in at $9.4 million versus the consensus estimate of $9.35 million.

GUIDANCE:

Apyx Medical Corp. sees FY2025 revenue of $47.6-49 million, versus the consensus of $48.03 million.

For earnings history and earnings-related data on Apyx Medical Corp. (APYX) click here.

You May Also Be Interested In

• Solstice acquiring Element Solutions in $14.5B cash and stock deal
• UAE crude output rises to near-record 3.8M barrels per day in June - Reuters
• Contango Silver & Gold converts gold hedges to debt, cuts rate